2017 ASCO-SITC Clinical Immuno-Oncology Symposium, Orlando, FL, February 23-25, 2016
- Jeremiah Oyer, Sarah B. Gitto, Deborah Altomare, Dean A. Lee, Alicja Copik “Preclinical assessment of PM21-particle expanded natural killer cells for ovarian cancer treatment.” J Clin Oncol 35, 2017 (suppl 7S; abstract 127)
- Jeremiah Oyer, Sarah B. Gitto, Sara Khederzadeh, Kari Shaver, Dean A. Lee, Deborah Altomare, Alicja Copik. “Assessment of antitumor function of NK cells expanded with exosomes from K562.mb21 cells.” J Clin Oncol 35, 2017 (suppl 7S; abstract 132)
NANOFLORIDA2016, Orlando, FL, September 26-27, 2016
Sara Khederzadeh, Kari Shaver, Jeremiah L. Oyer, Robert Igarashi, Alicja J. Copik “Expansion of Natural Killer Cells with Engineered Exosomes for Use in Cancer Treatment”
15th Meeting of the Society for Natural Immunity, Montebello, Quebec, Canada, May 2-6, 2015
Jeremiah Oyer, Veethika Pandey, Robert Y. Igarashi, Dominic Colosimo, Melhem M. Solh, Dean A. Lee, Deborah A. Altomare and Alicja Copik “NK cells stimulated with PM21 particles expand in vivo: potential for clinical applications.” Poster presentation
International Symposium on Inflammation and Health, Orlando FL, October 15-17, 2015
Jeremiah Oyer, Veethika Pandey, Robert Y. Igarashi, Dominic Colosimo, Melhem M. Solh, Deborah A. Altomare and Alicja Copik “Immune Cell Expansion, In Vivo Trafficking and Natural Killer Cell Anti-Tumor Efficacy in a Preclinical Model of Human Ovarian Cancer” Poster presentation
BMT Tandem Meetings, San Diego, CA Feb 11-15th, 2015
Jeremiah Oyer, Veethika Pandey, Robert Y. Igarashi, Dominic Colosimo, Melhem M. Solh, Deborah A. Altomare and Alicja Copik “In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2” Oral presentation
AACR Tumor Immunology and Immunotherapy: A New Chapter meeting Orlando, FL, Dec 1-4, 2014
Jeremiah L, Oyer, Veethika Pandey, Rania Bassiouni, Robert Y. Igarashi, Annette Khaled, Ahmed Zakari, Melhem Solh, Deborah A. Altomare and Alicja J. Copik. “Natural killer cells expanded with PM21 particles are cytotoxic toward tumor cells”. Poster presentation
56th American Society of Hematology meeting, San Francisco, CA, Dec. 6-9, 2014
Jeremiah Oyer, Veethika Pandey, Robert Y. Igarashi, Dominic Colosimo, Melhem M. Solh, Deborah A. Altomare, Alicja J. Copik “In Vitro Preactivation of PBMCs with PM-mb21-41BBL Particles Stimulates in Vivo Expansion of NK Cells Under Low IL-2 in NSG Mice” Poster presentation
5th Southeast Flow Cytometry Interest Group Annual Meeting, Tampa, FL, March 6-7, 2014
“NK cell immunotherapy of leukemia” invited speaker
BMT Tandem Meeting, Grapevine, TX, February 26 – March 2, 2014
Melhem M. Solh, Tori Smith, Alicja Copik, Yasser Khaled “Effect of “Mobilization Method on Immune Reconstitution Post High Dose Chemotherapy and Autologous Stem Cell Transplantation”
55th American Society of Hematology Annual Meeting, New Orleans, LA, December 7-10, 2013
- Jeremiah Oyer, Robert Y. Igarashi, Dominic Colosimo, Melhem M. Solh, Yasser Khaled, Alicja J. Copik “Generation Of Clinical Grade, Highly Cytotoxic NK Cells Using Feeder Cell Free, Particle-Based Technology”
- Melhem M. Solh, Tori Smith, Yasser Khaled, and Alicja Copik, “Effect Of Plerixafor Mobilization On Immune Reconstitution Post High Dose Chemotherapy and Autologous Stem Cell Transplantation”
- Abraham Matar, Melhem M. Solh, Alicja J. Copik, Sally Litherland, Alvin Oliveras Almodovar, Kristin Rathmann and Yasser Khaled “Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HCT) For Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Following Intravenous Busulfan/Fludarabine Based Conditioning: Outcomes and Monocyte Chemo-Attractant Protein -1( MCP-1) As a Predictive Marker Of Relapse”